Filing Details
- Accession Number:
- 0000950170-25-098542
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-24 20:32:18
- Reporting Period:
- 2025-07-22
- Filing Date:
- 2025-07-24
- Accepted Time:
- 2025-07-24 20:32:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1794546 | Carlsmed Inc. | CARL | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1416947 | Kevin Sidow | C/O Carlsmed, Inc. 1800 Aston Ave., Suite 100 Carlsbad CA 92008 | No | No | No | No |
Transaction Summary
Purchased: | 13,333 shares | Avg. Price: $15.00 | Total Value: $199,995.00 |
Number of Shares After Transactions: | 59,566 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-07-22 | 17,333 | $0.00 | 17,333 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2025-07-24 | 28,900 | $0.00 | 28,900 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2025-07-24 | 13,333 | $15.00 | 59,566 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | M | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Preferred Stock | Disposition | 2025-07-24 | 28,900 | $0.00 | 28,900 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct |
Footnotes
- Constitute an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in equal annual installments over three years.
- Includes 17,333 unvested restricted stock units convertible into approximately 17,333 shares of the Issuer's common stock.
- These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date.
- Includes 13,333 shares of the Issuer's common stock purchased by the Reporting Person in the Issuer's initial public offering at the public offering price of $15.00 per share. The purchase was made directly from the underwriters in connection with the offering.
- Includes (i) 17,333 unvested RSUs convertible into approximately 17,333 shares of the Issuer's common stock, (ii) 28,900 shares of common stock issued to Reporting Person upon the conversion of outstanding preferred stock on a 1-to-1 basis, immediately prior to the closing of the Issuer's public offering, and (iii) 13,333 shares of the Issuer's common stock purchased by the Reporting Person in the Issuer's initial public offering at the public offering price of $15.00 per share.